Gevo and Butamax have entered into worldwide patent cross-license and settlement agreements, ending a patent disputerelated to technologies for the production of bio-based isobutanol_by chemwinfo

24 August 2015

ABOUT GEVO

VIEW GEVO FULL ISOBUTANOL BROCHURE

ABOUT BUTAMAX

Butamax™ Advanced Biofuels LLC

Experimental Station / 356

200 Powder Mill Road

P.O. Box 8352

Wilmington, DE 19803

DETAILS

Butamax and Gevo

Enter Into Global Patent Cross-License and Settlement Agreements

to Accelerate Development of Markets

for Bio-Based Isobutanol and End All Litigation.

Factsheet: Butamax and Gevo

Patent Cross-License and Settlement Agreements

• Butamax and Gevo have agreed to global settlement and
  cross license agreements resolving
  the ongoing intellectual property dispute and
  all current district court litigations
  will be dismissed by the parties.
  
  
• Under the agreements Butamax and Gevo 
  have licensed all of their respective patents to each other,
  with rights to sub-license their respective technologies.
  
  
• Both parties are free to sell up to 30 million gallons per year
  royalty-free into any field, after which,
  certain fields bear royalties per the following table:

READ MORE

CONTACT: 
Media Contact
Karen Freedman / David Rodewald
The David James Agency, LLC
+1 805-494-9508
gevo@davidjamesagency.com

Investor Contact
Mike Willis
Gevo, Inc.
+1 720-267-8636
mwillis@gevo.com

WWW.CHEMWINFO.COM  BY KHUN PHICHAI